Eugia Pharma Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for EUGIA PHARMA, and what generic alternatives to EUGIA PHARMA drugs are available?
EUGIA PHARMA has one hundred and forty-two approved drugs.
There is one US patent protecting EUGIA PHARMA drugs. There are seven tentative approvals on EUGIA PHARMA drugs.
There are ten patent family members on EUGIA PHARMA drugs in nine countries and two hundred and sixty-one supplementary protection certificates in fifteen countries.
Summary for Eugia Pharma
International Patents: | 10 |
US Patents: | 1 |
Tradenames: | 118 |
Ingredients: | 110 |
NDAs: | 142 |
Patent Litigation for Eugia Pharma: | See patent lawsuits for Eugia Pharma |
Drugs and US Patents for Eugia Pharma
International Patents for Eugia Pharma Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 3139929 | See Plans and Pricing |
Canada | 2948148 | See Plans and Pricing |
World Intellectual Property Organization (WIPO) | 2015171460 | See Plans and Pricing |
Russian Federation | 2016147362 | See Plans and Pricing |
Japan | 6516831 | See Plans and Pricing |
Australia | 2015256331 | See Plans and Pricing |
Brazil | 112016026140 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Eugia Pharma Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1189916 | 2011C/004 | Belgium | See Plans and Pricing | PRODUCT NAME: REGADENOSON; AUTHORISATION NUMBER AND DATE: EU/1/10/643/001 20100906 |
0275821 | 01C0035 | France | See Plans and Pricing | PRODUCT NAME: ZOLEDRONIC ACID; NAT REG. NO/DATE: EU/1/01/176/001 20010320; FIRST REG.: LI IKS N 55 463 20001128 |
2785706 | C02785706/01 | Switzerland | See Plans and Pricing | PRODUCT NAME: FOSNETUPITANT, PALONOSETRON.; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 68290 01.09.2022 |
2563920 | CR 2019 00001 | Denmark | See Plans and Pricing | PRODUCT NAME: INOTERSEN AND SALT THEREOF, INCLUDING SODIUM SALTS; REG. NO/DATE: EU/1/18/1296 20180710 |
1856135 | 2090014-8 | Sweden | See Plans and Pricing | PRODUCT NAME: FOSTAMATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, OR A HYDRATE OR SOLVATE OF FOSTAMATINIB OR THE PH ARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, ESPECIALLY FOSTAMATINIB DISODIUM, OPTIONALLY IN FORM OF A HYDRATE; REG. NO/DATE: EU/1/19/1405 20200113 |
0863901 | PA2004008 | Lithuania | See Plans and Pricing | PRODUCT NAME: ERTAPENEMUM ([4R,5S,6S]-3-[(3S,5S)-5-[(3-KARBOKSIFENIL) AMINO]KARBONIL]-3-PIROLIDINIL]TIO]-6-[(1R)-1HIDROKSIETIL]-4-METIL-7-OKSO-1-AZABICIKLO-[3.2.0]HEPT-2-EN-2-KARBOKSIRUGSTIS; REGISTRATION NO/DATE: 03/8043/3 20030328 |
0296749 | 09C0055 | France | See Plans and Pricing | PRODUCT NAME: ANASTROZOLE, EVENTUELLEMENT SOUS LA FORME DUN SEL DADDITION ACCEPTABLE EN MEDECINE PHARMACEUTIQUE; REGISTRATION NO/DATE IN FRANCE: NL 21126 DU 19961227; REGISTRATION NO/DATE AT EEC: 12619/0106 DU 19950811 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.